View Author
scopus: 6508124657

Rolleman, E.J.

(Edgar Rolleman)


kidney uptake patient somatostatin gelofusine radiolabelled somatostatin analogues peptide radiolabelled study radiation analogue imaging receptor therapy jong m tumour effect radionuclide tumours treatment retention reduction krenning ep lysine toxicity kidney uptake radiation dose krenning dosimetry group valkema r y-dota radiation nephropathy radiolabelled peptides control lu-dota bernard bf radioactivity result rolleman bakker wh reabsorption valkema combination in-dota administration nephropathy in-dtpa octreotide bernard damage somatostatin analogues infusion function tumour uptake activity kooij pp breeman wa radiolabelled octreotate visser tj 20948 tumours wetzels jf cremonesi m visser method tumor neuroendocrine radiolabeled acid solutions solution biodistribution barone mechanism cancer albumin fragments vivo autoradiography kidney protection megalin protection factor




9 Most Recent Publications

Kidney protection during peptide receptor radionuclide therapy with somatostatin analogues (Article)
Rolleman, E.J. Melis, M.L. Valkema, R. Boerman, O.C. Krenning, E.P. Jong, M. de
2010-05-01
Dose-response effect of Gelofusine on renal uptake and retention of radiolabelled octreotate in rats with CA20948 tumours (Article)
Melis, M.L. Bijster, M. Visser, M. de Konijnenberg, M.W. Swart, J. de Rolleman, E.J. Boerman, O.C. Krenning, E.P. Jong, M. de
2009-12-01
Acute nephritic syndrome after anti-VEGF therapy for renal cell carcinoma (Article)
Rolleman, E.J. Weening, J.J. Betjes, M.G.H.
2009-06-01
Somatostatin receptor subtype 2-mediated uptake of radiolabelled somatostatin analogues in the human kidney (Article)
Rolleman, E.J. Kooij, P.P.M. Herder, W.W. de Valkema, R. Krenning, E.P. Jong, M. de
2007-11-01
Renal uptake and retention of radiolabeled somatostatin, bombesin, neurotensin, minigastrin and CCK analogues: species and gender differences (Article)
Melis, M.L. Krenning, E.P. Bernard, B.F. Visser, M. de Rolleman, E.J. Jong, M. de
2007-08-01
Amifostine protects rat kidneys during peptide receptor radionuclide therapy with [177Lu-DOTA0,Tyr3]octreotate (Article)
Rolleman, E.J. Forrer, F. Bernard, B.F. Bijster, M. Vermeij, M. Valkema, R. Krenning, E.P. Jong, M. de
2007-05-01
Indication for different mechanisms of kidney uptake of radiolabeled peptides (Article)
Gotthardt, M. Eerd-Vismale, J. van Oyen, W.J. Jong, M. de Zhang, H. Rolleman, E.J. Maecke, H.R. Béhé, M. Boerman, O.C.
2007-04-01
Long-term toxicity of [177Lu-DOTA0,Tyr 3]octreotate in rats (Article)
Rolleman, E.J. Krenning, E.P. Bernard, B.F. Visser, M. de Bijster, M. Visser, T.J. Vermeij, M. Lindemans, J. Jong, M. de
2007-02-01
Anaphylactoid reaction from amifostine (Article)
Rolleman, E.J. Forrer, F. Deckers, J. Groot, H. de Valkema, R. Jong, M. de Krenning, E.P.
2007-01-01